Glutamate and the neural basis of the subjective effects of ketamine

被引:235
作者
Deakin, J. F. William [1 ]
Lees, Jane [1 ]
Mckie, Shane [1 ]
Hallak, Jaime E. C. [1 ,2 ]
Williams, Steve R.
Dursun, Serdar M. [1 ]
机构
[1] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Neurol Psychiat & Psychol Med Dept, Sao Paulo, Brazil
基金
英国医学研究理事会;
关键词
D O I
10.1001/archgenpsychiatry.2007.37
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Ketamine evokes psychosislike symptoms, and its primary action is to impair N-methyl-D-aspartate glutamate receptor neurotransmission, but it also induces secondary increases in glutamate release. Objectives: To identify the sites of action of ketamine in inducing symptoms and to determine the role of increased glutamate release using the glutamate release inhibitor lamotrigine. Design: Two experiments with different participants were performed using a double-blind, placebo-controlled, randomized, crossover, counterbalanced-order design. In the first experiment, the effect of intravenous ketamine hydrochloride on regional blood oxygenation level dependent (BOLD) signal and correlated symptoms was compared with intravenous saline placebo. In the second experiment, pretreatment with lamotrigine was compared with placebo to identify which effects of ketamine are mediated by increased glutamate release. Setting: Wellcome Trust Clinical Research Facility, Manchester, England. Participants: Thirty-three healthy, right-handed men were recruited by advertisements. Interventions: In experiment 1, participants were given intravenous ketamine (1-minute bolus of 0.26 mg/ kg, followed by a maintenance infusion of 0.25 mg/ kg/ h for the remainder of the session) or placebo (0.9% saline solution). In experiment 2, participants were pretreated with 300 mg of lamotrigine or placebo and then were given the same doses of ketamine as in experiment 1. Main Outcome Measures: Regional BOLD signal changes during ketamine or placebo infusion and Brief Psychiatric Rating Scale and Clinician- Administered Dissociative States Scale scores. Results: Ketamine induced a rapid, focal, and unexpected decrease in ventromedial frontal cortex, including orbitofrontal cortex and subgenual cingulate, which strongly predicted its dissociative effects and increased activity in mid- posterior cingulate, thalamus, and temporal cortical regions (r= 0.90). Activations correlated with Brief Psychiatric Rating Scale psychosis scores. Lamotrigine pretreatment prevented many of the BOLD signal changes and the symptoms. Conclusions: These 2 changes may underpin 2 fundamental processes of psychosis: abnormal perceptual experiences and impaired cognitive- emotional evaluation of their significance. The results are compatible with the theory that the neural and subjective effects of ketamine involve increased glutamate release.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 62 条
  • [1] Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man
    Aalto, S
    Ihalainen, J
    Hirvonen, J
    Kajander, J
    Scheinin, H
    Tanila, H
    Någren, K
    Vilkman, H
    Gustafsson, LL
    Syvälahti, E
    Hietala, J
    [J]. PSYCHOPHARMACOLOGY, 2005, 182 (03) : 375 - 383
  • [2] Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state
    Abel, KM
    Allin, MPG
    Kucharska-Pietura, K
    Andrew, C
    Williams, S
    David, AS
    Phillips, ML
    [J]. HUMAN BRAIN MAPPING, 2003, 18 (02) : 135 - 145
  • [3] Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia
    Adler, CM
    Malhotra, AK
    Elman, I
    Goldberg, T
    Egan, M
    Pickar, D
    Breier, A
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (10) : 1646 - 1649
  • [4] Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
    Anand, A
    Charney, DS
    Oren, DA
    Berman, RM
    Hu, XS
    Cappiello, A
    Krystal, JH
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (03) : 270 - 276
  • [5] 5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI
    Anderson, IM
    Clark, L
    Elliott, R
    Kulkarni, B
    Williams, SR
    Deakin, JFW
    [J]. NEUROREPORT, 2002, 13 (12) : 1547 - 1551
  • [6] Antidepressant effects of ketamine in depressed patients
    Berman, RM
    Cappiello, A
    Anand, A
    Oren, DA
    Heninger, GR
    Charney, DS
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (04) : 351 - 354
  • [7] Bleuler E, 1908, ALLG Z PSYCHIAT, V65, P436
  • [8] Bloom AS, 1999, HUM BRAIN MAPP, V8, P235, DOI 10.1002/(SICI)1097-0193(1999)8:4<235::AID-HBM7>3.0.CO
  • [9] 2-3
  • [10] Does glutamate image your thoughts?
    Bonvento, G
    Sibson, N
    Pellerin, L
    [J]. TRENDS IN NEUROSCIENCES, 2002, 25 (07) : 359 - 364